IL6 and lung carcinoma: To examine whether USP24-mediated IL-6 was indeed functioning in lung cancer metastasis and angiogenesis, IL-6 was added to conditioned medium derived from USP24-knockdown M2 macrophages to address malignant lung cancer cell activity (Fig. 3o–q).